Publication | Closed Access

Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner

Tumor BiologyOncologyGliomaMedicinePharmacologyTherapeutic SensitivityAnti-cancer AgentTumor SuppressorCancer TreatmentCancer BiologyCell Biology-Independent MannerCancer ResearchCancer Growth